Multi-university TTO Satt Sud-Est has licensed patents to GenOmnis for an RNA-based bioinformatics technology that will assess the pathogenicity of biological organisms.

Harare Institute of Technology's new tech transfer office is currently preparing documents to secure its policy base after assisting president Emmerson Mnangagwa's "100-day" drive earlier this year.

Institut Curie has supplied an undisclosed sum to its second immuno-oncology spinout, Honing Biosciences, which will focus on improved drug delivery mechanisms.

Duke University’s OLV managed a near-50% increase on 2017’s spinout tally in a year where its businesses generated $526m in capital.

Elevian will commercialise research from Harvard and Stanford indicating young blood cells could be used to restore tissues in older patients.

University of Queensland revealed it has generated more than 100 spinouts since 1988, with probiotic drink manufacturer Perkii becoming number 100 in 2016.

Sentea has been spun out with $1.9m in seed funding to commercialise fibre optic sensor technologies that monitor engineering structures for wear and damage.

Matarki Bioscience has been spun out under a drug discovery model to carry Warsaw pharmaceutical research through pre-clinical and early clinical trials.

Discern will commercialise a deception tracker nicknamed Avatar designed to initially be deployed at border security and based on research at Arizona.

Prapela will commercialise medical devices for infants administering to fight drug withdrawal and cardiorespiratory problems.